Simon Pedder - 08 Sep 2025 Form 4 Insider Report for ADAPTIN BIO, INC.

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ S. Halle Vakani, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Sep 2025
Net transactions value
$0
Form type
4
Filing time
10 Sep 2025, 16:59:40 UTC
Previous filing
18 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pedder Simon Executive Chairman, Director, 10%+ Owner 3540 TORINGDON WAY, SUITE 200, #250, CHARLOTTE /s/ S. Halle Vakani, Attorney-in-Fact 10 Sep 2025 0001316736

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Common Stock 928,571 08 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Stock Option (right to buy) Award $0 +192,231 $0.000000 192,231 08 Sep 2025 Common Stock 192,231 $4.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025.